AAAAAA

   
Results: 1-25 | 26-47
Results: 1-25/47
Selective serotonin reuptake inhibitor antidepressants: Cardiovascular complications - Sorting through findings
Authors: Shader, RI Greenblatt, DJ
Citation: Ri. Shader et Dj. Greenblatt, Selective serotonin reuptake inhibitor antidepressants: Cardiovascular complications - Sorting through findings, J CL PSYCH, 21(5), 2001, pp. 467-468
Drug interactions with grapefruit juice: An update
Authors: Greenblatt, DJ Patki, KC von Moltke, LL Shader, RI
Citation: Dj. Greenblatt et al., Drug interactions with grapefruit juice: An update, J CL PSYCH, 21(4), 2001, pp. 357-359
A retrospective study of children's perceptions of participation as clinical research subjects in a minimal risk study
Authors: Fogas, BS Oesterheld, JR Shader, RI
Citation: Bs. Fogas et al., A retrospective study of children's perceptions of participation as clinical research subjects in a minimal risk study, J DEV BEH P, 22(4), 2001, pp. 211-216
A benzodiazepine mood effect scale: Reliability and validity determined for alcohol-dependent subjects and adults with a parental history of alcoholism
Authors: Ciraulo, DA Knapp, CM LoCastro, J Greenblatt, DJ Shader, RI
Citation: Da. Ciraulo et al., A benzodiazepine mood effect scale: Reliability and validity determined for alcohol-dependent subjects and adults with a parental history of alcoholism, AM J DRUG A, 27(2), 2001, pp. 339-347
Pharmacodynamic and receptor binding changes during chronic lorazepam administration
Authors: Fahey, JM Pritchard, GA Grassi, JM Pratt, JS Shader, RI Greenblatt, DJ
Citation: Jm. Fahey et al., Pharmacodynamic and receptor binding changes during chronic lorazepam administration, PHARM BIO B, 69(1-2), 2001, pp. 1-8
Relative contribution of CYP3A to amitriptyline clearance in humans: In vitro and in vivo studies
Authors: Venkatakrishnan, K Schmider, J Harmatz, JS Ehrenberg, BL von Moltke, LL Graf, JA Mertzanis, P Corbett, KE Rodriguez, MC Shader, RI Greenblatt, DJ
Citation: K. Venkatakrishnan et al., Relative contribution of CYP3A to amitriptyline clearance in humans: In vitro and in vivo studies, J CLIN PHAR, 41(10), 2001, pp. 1043-1054
Inhibition of human cytochrome P450 isoforms by nonnucleoside reverse transcriptase inhibitors
Authors: von Moltke, LL Greenblatt, DJ Granda, BW Giancarlo, GM Duan, SX Daily, JP Harmatz, JS Shader, RI
Citation: Ll. Von Moltke et al., Inhibition of human cytochrome P450 isoforms by nonnucleoside reverse transcriptase inhibitors, J CLIN PHAR, 41(1), 2001, pp. 85-91
Escitalopram (S-citalopram) and its metabolites in vitro: cytochromes mediating biotransformation, inhibitory effects, and comparison to R-citalopram
Authors: Von Moltke, LL Greenblatt, DJ Giancarlo, GM Granda, BW Harmatz, JS Shader, RI
Citation: Ll. Von Moltke et al., Escitalopram (S-citalopram) and its metabolites in vitro: cytochromes mediating biotransformation, inhibitory effects, and comparison to R-citalopram, DRUG META D, 29(8), 2001, pp. 1102-1109
Ritonavir, efavirenz, and nelfinavir inhibit CYP2B6 activity in vitro: Potential drug interactions with bupropion
Authors: Hesse, LM von Moltke, LL Shader, RI Greenblatt, DJ
Citation: Lm. Hesse et al., Ritonavir, efavirenz, and nelfinavir inhibit CYP2B6 activity in vitro: Potential drug interactions with bupropion, DRUG META D, 29(2), 2001, pp. 100-102
CYP3A4 is the major CYP isoform mediating the in vitro hydroxylation and demethylation of flunitrazepam
Authors: Hesse, LM Venkatakrishnan, K Von Moltke, LL Shader, RI Greenblatt, DJ
Citation: Lm. Hesse et al., CYP3A4 is the major CYP isoform mediating the in vitro hydroxylation and demethylation of flunitrazepam, DRUG META D, 29(2), 2001, pp. 133-140
Differential impairment of triazolam and zolpidem clearance by ritonavir
Authors: Greenblatt, DJ von Moltke, LL Harmatz, JS Durol, ALB Daily, JP Graf, JA Mertzanis, P Hoffman, JL Shader, RI
Citation: Dj. Greenblatt et al., Differential impairment of triazolam and zolpidem clearance by ritonavir, J ACQ IMM D, 24(2), 2000, pp. 129-136
More on oral contraceptives, drug interactions, herbal medicines, and hormone replacement therapy
Authors: Shader, RI Greenblatt, DJ
Citation: Ri. Shader et Dj. Greenblatt, More on oral contraceptives, drug interactions, herbal medicines, and hormone replacement therapy, J CL PSYCH, 20(4), 2000, pp. 397-398
Differences in pharmacodynamics but not pharmacokinetics between subjects with panic disorder and healthy subjects after treatment with a single doseof alprazolam
Authors: Kaplan, GB Greenblatt, DJ Ehrenberg, BL Goddard, JE Harmatz, JS Shader, RI
Citation: Gb. Kaplan et al., Differences in pharmacodynamics but not pharmacokinetics between subjects with panic disorder and healthy subjects after treatment with a single doseof alprazolam, J CL PSYCH, 20(3), 2000, pp. 338-346
Contraceptive effectiveness: Cytochromes and induction
Authors: Shader, RI Oesterheld, JR
Citation: Ri. Shader et Jr. Oesterheld, Contraceptive effectiveness: Cytochromes and induction, J CL PSYCH, 20(2), 2000, pp. 119-121
Welcome to a new decade and to the year 2000
Authors: Shader, RI Greenblatt, DJ
Citation: Ri. Shader et Dj. Greenblatt, Welcome to a new decade and to the year 2000, J CL PSYCH, 20(1), 2000, pp. 1-1
Decreased EEG sensitivity to alprazolam in subjects with a parental history of alcoholism
Authors: Sarid-Segal, O Knapp, CM Ciraulo, AM Greenblatt, DJ Shader, RI Ciraulo, DA
Citation: O. Sarid-segal et al., Decreased EEG sensitivity to alprazolam in subjects with a parental history of alcoholism, J CLIN PHAR, 40(1), 2000, pp. 84-90
In vitro biotransformation of sildenafil (Viagra): Identification of humancytochromes and potential drug interactions
Authors: Warrington, JS Shader, RI von Moltke, LL Greenblatt, DJ
Citation: Js. Warrington et al., In vitro biotransformation of sildenafil (Viagra): Identification of humancytochromes and potential drug interactions, DRUG META D, 28(4), 2000, pp. 392-397
Metabolism of the antidepressant mirtazapine in vitro: Contribution of cytochromes P-450 1A2, 2D6, and 3A4
Authors: Stormer, E Von Moltke, LL Shader, RI Greenblatt, DJ
Citation: E. Stormer et al., Metabolism of the antidepressant mirtazapine in vitro: Contribution of cytochromes P-450 1A2, 2D6, and 3A4, DRUG META D, 28(10), 2000, pp. 1168-1175
CYP2B6 mediates the in vitro hydroxylation of bupropion: Potential drug interactions with other antidepressants
Authors: Hesse, LM Venkatakrishnan, K Court, MH Von Moltke, LL Duan, SX Shader, RI Greenblatt, DJ
Citation: Lm. Hesse et al., CYP2B6 mediates the in vitro hydroxylation of bupropion: Potential drug interactions with other antidepressants, DRUG META D, 28(10), 2000, pp. 1176-1183
Kinetics and dynamics of lorazepam during and after continuous intravenousinfusion
Authors: Greenblatt, DJ von Moltke, LL Ehrenberg, BL Harmatz, JS Corbett, KE Wallace, DW Shader, RI
Citation: Dj. Greenblatt et al., Kinetics and dynamics of lorazepam during and after continuous intravenousinfusion, CRIT CARE M, 28(8), 2000, pp. 2750-2757
Comparative kinetics and response to the benzodiazepine agonists triazolamand zolpidem: Evaluation of sex-dependent differences
Authors: Greenblatt, DJ Harmatz, JS von Moltke, LL Wright, CE Durol, ALB Harrel-Joseph, LM Shader, RI
Citation: Dj. Greenblatt et al., Comparative kinetics and response to the benzodiazepine agonists triazolamand zolpidem: Evaluation of sex-dependent differences, J PHARM EXP, 293(2), 2000, pp. 435-443
Effects of age on in vitro midazolam biotransformation in male CD-1 mouse liver microsomes
Authors: Warrington, JS Poku, JW Von Moltke, LL Shader, RI Harmatz, JS Greenblatt, DJ
Citation: Js. Warrington et al., Effects of age on in vitro midazolam biotransformation in male CD-1 mouse liver microsomes, J PHARM EXP, 292(3), 2000, pp. 1024-1031
Midazolam and triazolam biotransformation in mouse and human liver microsomes: Relative contribution of CYP3A and CYP2C isoforms
Authors: Perloff, MD von Moltke, LL Court, MH Kotegawa, T Shader, RI Greenblatt, DJ
Citation: Md. Perloff et al., Midazolam and triazolam biotransformation in mouse and human liver microsomes: Relative contribution of CYP3A and CYP2C isoforms, J PHARM EXP, 292(2), 2000, pp. 618-628
Alprazolam-ritonavir interaction: Implications for product labeling
Authors: Greenblatt, DJ von Moltke, LL Harmatz, JS Durol, ALB Daily, JP Graf, JA Mertzanis, P Hoffman, JL Shader, RI
Citation: Dj. Greenblatt et al., Alprazolam-ritonavir interaction: Implications for product labeling, CLIN PHARM, 67(4), 2000, pp. 335-341
In vitro metabolism of trazodone by CYP3A: Inhibition by ketoconazole and human immunodeficiency viral protease inhibitors
Authors: Zalma, A von Moltke, LL Granda, BW Harmatz, JS Shader, RI Greenblatt, DJ
Citation: A. Zalma et al., In vitro metabolism of trazodone by CYP3A: Inhibition by ketoconazole and human immunodeficiency viral protease inhibitors, BIOL PSYCHI, 47(7), 2000, pp. 655-661
Risultati: 1-25 | 26-47